Skingenix, Inc.
Quick facts
Marketed products
- MEBO Wound Ointment · Dermatology / Wound Care
MEBO Wound Ointment promotes wound healing through a combination of herbal extracts and oils that enhance tissue regeneration and reduce inflammation.
Phase 3 pipeline
- MEBO Wound Ointment (MEBO) · Dermatology / Wound Care
MEBO Wound Ointment promotes wound healing by creating a moist healing environment and stimulating tissue regeneration and epithelialization.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Skingenix, Inc.
What are Skingenix, Inc.'s marketed drugs?
Top marketed products include MEBO Wound Ointment.
What is Skingenix, Inc.'s pipeline?
Skingenix, Inc. has 1 drugs in Phase 3, 2 in Phase 2, 0 in Phase 1. Late-stage candidates include MEBO Wound Ointment (MEBO).
Related
- MEBO Wound Ointment · Dermatology / Wound Care
- Sector hub: All tracked pharma companies